Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Illness | 18 | 2017 | 2670 | 0.810 |
Why?
|
| Vitamin D Deficiency | 9 | 2015 | 1343 | 0.430 |
Why?
|
| Vitamin D | 10 | 2015 | 3223 | 0.410 |
Why?
|
| Interleukin-13 | 4 | 2006 | 389 | 0.350 |
Why?
|
| Hospital Mortality | 10 | 2016 | 5317 | 0.280 |
Why?
|
| Tosyl Compounds | 1 | 2005 | 113 | 0.260 |
Why?
|
| Leukotriene Antagonists | 1 | 2005 | 127 | 0.250 |
Why?
|
| Budesonide | 1 | 2005 | 154 | 0.250 |
Why?
|
| Interferon-gamma | 4 | 2006 | 3206 | 0.220 |
Why?
|
| Sepsis | 8 | 2017 | 2593 | 0.210 |
Why?
|
| Critical Care | 11 | 2016 | 2647 | 0.210 |
Why?
|
| Community-Acquired Infections | 3 | 2014 | 465 | 0.200 |
Why?
|
| Intensive Care Units | 10 | 2017 | 3679 | 0.190 |
Why?
|
| Prednisone | 1 | 2005 | 1574 | 0.190 |
Why?
|
| Boston | 15 | 2017 | 9313 | 0.170 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2006 | 810 | 0.170 |
Why?
|
| Acute Kidney Injury | 3 | 2016 | 1972 | 0.150 |
Why?
|
| Smoke Inhalation Injury | 1 | 2017 | 49 | 0.150 |
Why?
|
| Erythroblasts | 1 | 2017 | 150 | 0.140 |
Why?
|
| Logistic Models | 14 | 2017 | 13408 | 0.140 |
Why?
|
| Hospitalization | 9 | 2017 | 10262 | 0.140 |
Why?
|
| Erythrocyte Indices | 2 | 2014 | 146 | 0.140 |
Why?
|
| Glucocorticoids | 1 | 2005 | 2107 | 0.140 |
Why?
|
| Hypernatremia | 1 | 2016 | 82 | 0.130 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2006 | 1832 | 0.130 |
Why?
|
| Fetal Blood | 3 | 2006 | 1318 | 0.130 |
Why?
|
| Cross Infection | 2 | 2014 | 1416 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2006 | 1836 | 0.120 |
Why?
|
| Odds Ratio | 10 | 2017 | 9849 | 0.120 |
Why?
|
| Lung | 2 | 2015 | 9856 | 0.110 |
Why?
|
| Acid-Base Equilibrium | 1 | 2013 | 185 | 0.100 |
Why?
|
| Craniotomy | 1 | 2016 | 729 | 0.100 |
Why?
|
| Erythrocyte Volume | 1 | 2011 | 30 | 0.100 |
Why?
|
| Residence Characteristics | 2 | 2012 | 2050 | 0.100 |
Why?
|
| End Stage Liver Disease | 1 | 2016 | 314 | 0.100 |
Why?
|
| Blood Urea Nitrogen | 1 | 2011 | 191 | 0.100 |
Why?
|
| Pneumonia | 3 | 2015 | 2133 | 0.100 |
Why?
|
| Health Status Indicators | 2 | 2014 | 969 | 0.090 |
Why?
|
| Poverty Areas | 1 | 2012 | 275 | 0.090 |
Why?
|
| Hyperkalemia | 1 | 2012 | 218 | 0.090 |
Why?
|
| Survivors | 2 | 2017 | 2291 | 0.090 |
Why?
|
| Middle Aged | 30 | 2017 | 213383 | 0.090 |
Why?
|
| Hospitals, Teaching | 4 | 2015 | 1179 | 0.080 |
Why?
|
| Aged | 25 | 2017 | 163280 | 0.080 |
Why?
|
| Male | 38 | 2017 | 350118 | 0.080 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 1265 | 0.070 |
Why?
|
| Clostridium Infections | 1 | 2014 | 548 | 0.070 |
Why?
|
| Asthma | 1 | 2005 | 6011 | 0.070 |
Why?
|
| Bacteremia | 1 | 2013 | 962 | 0.070 |
Why?
|
| Ofloxacin | 1 | 2006 | 65 | 0.070 |
Why?
|
| Risk Factors | 16 | 2017 | 72290 | 0.070 |
Why?
|
| Female | 37 | 2017 | 380194 | 0.070 |
Why?
|
| Phenylcarbamates | 1 | 2005 | 38 | 0.070 |
Why?
|
| Phytohemagglutinins | 1 | 2005 | 170 | 0.070 |
Why?
|
| Burns | 1 | 2017 | 1815 | 0.070 |
Why?
|
| Cohort Studies | 11 | 2017 | 40561 | 0.070 |
Why?
|
| Mortality | 1 | 2017 | 2864 | 0.070 |
Why?
|
| Multivariate Analysis | 6 | 2017 | 12245 | 0.070 |
Why?
|
| Tuberculin Test | 1 | 2006 | 214 | 0.070 |
Why?
|
| Cause of Death | 2 | 2017 | 3584 | 0.070 |
Why?
|
| Lung Diseases | 1 | 2015 | 1886 | 0.060 |
Why?
|
| Creatinine | 1 | 2011 | 1919 | 0.060 |
Why?
|
| APACHE | 2 | 2017 | 277 | 0.060 |
Why?
|
| Metronidazole | 1 | 2006 | 217 | 0.060 |
Why?
|
| Aged, 80 and over | 13 | 2016 | 57776 | 0.060 |
Why?
|
| Ventilator Weaning | 1 | 2006 | 148 | 0.060 |
Why?
|
| Patient Discharge | 2 | 2016 | 3313 | 0.060 |
Why?
|
| Hemoptysis | 1 | 2006 | 155 | 0.060 |
Why?
|
| Cerebral Hemorrhage | 1 | 2016 | 2647 | 0.060 |
Why?
|
| Tomography, Emission-Computed | 1 | 2008 | 1144 | 0.060 |
Why?
|
| Adult | 21 | 2017 | 214055 | 0.060 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2006 | 120 | 0.060 |
Why?
|
| Patient Readmission | 2 | 2017 | 3114 | 0.060 |
Why?
|
| Retrospective Studies | 15 | 2017 | 77449 | 0.060 |
Why?
|
| Language | 1 | 2013 | 1471 | 0.060 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2006 | 456 | 0.060 |
Why?
|
| Delirium | 1 | 2015 | 1609 | 0.060 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 4560 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 2400 | 0.060 |
Why?
|
| Administration, Inhalation | 1 | 2005 | 1105 | 0.050 |
Why?
|
| Sarcoidosis | 1 | 2008 | 506 | 0.050 |
Why?
|
| Humans | 38 | 2017 | 744343 | 0.050 |
Why?
|
| Glucose | 3 | 1999 | 4397 | 0.050 |
Why?
|
| Endpoint Determination | 2 | 2015 | 601 | 0.050 |
Why?
|
| Confidence Intervals | 3 | 2011 | 2971 | 0.050 |
Why?
|
| Lymphocytes | 2 | 2006 | 2617 | 0.050 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 2759 | 0.050 |
Why?
|
| Immune System | 1 | 2005 | 805 | 0.040 |
Why?
|
| Poverty | 1 | 2011 | 2660 | 0.040 |
Why?
|
| Maternal Exposure | 1 | 2006 | 961 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 12959 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2006 | 972 | 0.040 |
Why?
|
| Duodenum | 2 | 1999 | 483 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15540 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2006 | 1809 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2005 | 5524 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2005 | 2263 | 0.040 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 1199 | 0.040 |
Why?
|
| Nitrogen | 1 | 1998 | 344 | 0.040 |
Why?
|
| Indoles | 1 | 2005 | 1839 | 0.040 |
Why?
|
| Body Surface Area | 1 | 2017 | 198 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2015 | 20129 | 0.040 |
Why?
|
| Risk Assessment | 5 | 2017 | 23338 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2005 | 1938 | 0.030 |
Why?
|
| Trauma Severity Indices | 1 | 2017 | 481 | 0.030 |
Why?
|
| Physical Exertion | 1 | 1998 | 695 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 6489 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 5751 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 2866 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15295 | 0.030 |
Why?
|
| Muscle, Skeletal | 3 | 1999 | 4931 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2006 | 2408 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3768 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2013 | 6365 | 0.030 |
Why?
|
| Inpatients | 2 | 2015 | 2518 | 0.030 |
Why?
|
| Fasting | 1 | 1999 | 1593 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 1996 | 362 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 684 | 0.030 |
Why?
|
| Pleural Effusion | 1 | 2015 | 338 | 0.030 |
Why?
|
| Multiple Organ Failure | 1 | 2015 | 390 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 12354 | 0.030 |
Why?
|
| Intestinal Mucosa | 3 | 1999 | 3036 | 0.030 |
Why?
|
| Registries | 2 | 2017 | 8089 | 0.020 |
Why?
|
| Time Factors | 6 | 2014 | 40075 | 0.020 |
Why?
|
| Trauma Centers | 1 | 2016 | 890 | 0.020 |
Why?
|
| Survival Analysis | 3 | 2011 | 10252 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2015 | 862 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2015 | 39050 | 0.020 |
Why?
|
| Propensity Score | 1 | 2016 | 1781 | 0.020 |
Why?
|
| Surgery Department, Hospital | 1 | 2011 | 175 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2011 | 571 | 0.020 |
Why?
|
| Radiology Information Systems | 1 | 2014 | 523 | 0.020 |
Why?
|
| Adolescent | 4 | 2017 | 85781 | 0.020 |
Why?
|
| Dogs | 3 | 1999 | 3912 | 0.020 |
Why?
|
| Reperfusion Injury | 1 | 2015 | 1026 | 0.020 |
Why?
|
| Allergens | 2 | 2006 | 1320 | 0.020 |
Why?
|
| Social Class | 1 | 2017 | 1999 | 0.020 |
Why?
|
| Potassium | 1 | 2012 | 1336 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2014 | 783 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 13102 | 0.020 |
Why?
|
| Glycogen | 2 | 1999 | 260 | 0.020 |
Why?
|
| Liver | 3 | 1999 | 7474 | 0.020 |
Why?
|
| Hindlimb | 2 | 1999 | 504 | 0.020 |
Why?
|
| Glycerol | 2 | 1999 | 278 | 0.020 |
Why?
|
| Blood Glucose | 3 | 2013 | 6256 | 0.020 |
Why?
|
| Alanine | 2 | 1999 | 572 | 0.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1994 | 1873 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 1999 | 402 | 0.020 |
Why?
|
| Forecasting | 1 | 2015 | 2951 | 0.020 |
Why?
|
| Cell Proliferation | 3 | 2006 | 10481 | 0.020 |
Why?
|
| Length of Stay | 2 | 2011 | 6309 | 0.020 |
Why?
|
| Mitogens | 1 | 2005 | 232 | 0.020 |
Why?
|
| Glucagon | 2 | 1998 | 533 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 3527 | 0.020 |
Why?
|
| Lipid A | 1 | 2004 | 67 | 0.020 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2006 | 227 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2012 | 2682 | 0.010 |
Why?
|
| Biopsy | 1 | 2015 | 6756 | 0.010 |
Why?
|
| Vital Capacity | 1 | 2006 | 925 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2014 | 2708 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10388 | 0.010 |
Why?
|
| Peptidoglycan | 1 | 2004 | 246 | 0.010 |
Why?
|
| Lactic Acid | 2 | 1999 | 1133 | 0.010 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2004 | 354 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 2538 | 0.010 |
Why?
|
| Tracheostomy | 1 | 2006 | 401 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2011 | 2455 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 2006 | 25625 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 565 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 592 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10397 | 0.010 |
Why?
|
| Age Factors | 2 | 2015 | 18370 | 0.010 |
Why?
|
| Pain | 1 | 2015 | 4986 | 0.010 |
Why?
|
| Antigens | 1 | 2006 | 1466 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2015 | 5102 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2006 | 2618 | 0.010 |
Why?
|
| Pancreatic Hormones | 1 | 1999 | 13 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2004 | 1057 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2004 | 1061 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2008 | 2016 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1994 | 6077 | 0.010 |
Why?
|
| Spleen | 1 | 2004 | 2362 | 0.010 |
Why?
|
| Prognosis | 2 | 2011 | 29063 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 7785 | 0.010 |
Why?
|
| Incidence | 1 | 2016 | 20947 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2008 | 2645 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 19905 | 0.010 |
Why?
|
| Glycogen Synthase | 1 | 1996 | 62 | 0.010 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2006 | 1344 | 0.010 |
Why?
|
| Body Fluid Compartments | 1 | 1996 | 52 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1996 | 419 | 0.010 |
Why?
|
| Splanchnic Circulation | 1 | 1996 | 110 | 0.010 |
Why?
|
| Lactates | 1 | 1996 | 432 | 0.010 |
Why?
|
| Rheology | 1 | 1996 | 345 | 0.010 |
Why?
|
| Glutamine | 1 | 1998 | 578 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 4669 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 15076 | 0.010 |
Why?
|
| Pregnancy | 2 | 2006 | 29144 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1996 | 426 | 0.010 |
Why?
|
| Insulin | 2 | 1998 | 6580 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2015 | 63114 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 56430 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 19229 | 0.010 |
Why?
|
| Smoking | 1 | 2006 | 8987 | 0.010 |
Why?
|
| Animals | 4 | 2004 | 168757 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2004 | 23403 | 0.000 |
Why?
|
| Mice | 1 | 2004 | 81183 | 0.000 |
Why?
|
Concepts
(207)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_